Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Lung Cancer

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 27 articles:
HTML format



Single Articles


    November 2022
  1. BLUM TG, Morgan RL, Durieux V, Chorostowska-Wynimko J, et al
    European Respiratory Society Guideline on various aspects of quality in lung cancer care.
    Eur Respir J. 2022 Nov 17. pii: 13993003.03201-2021.
    PubMed     Abstract available


  2. MAGENHEIM J, Rokach A, Peretz A, Loyfer N, et al
    Universal lung epithelium DNA methylation markers for detection of lung damage in liquid biopsies.
    Eur Respir J. 2022;60.
    PubMed     Abstract available


    September 2022
  3. METZENMACHER M, Griesinger F, Hummel HD, Elender C, et al
    Prognostic factors in non-small-cell lung cancer: insights from the German crisp registry.
    Eur Respir J. 2022 Sep 30. pii: 13993003.01336-2022.
    PubMed     Abstract available


  4. GUISIER F, Deslee G, Birembaut P, Escarguel B, et al
    Endoscopic follow-up of low-grade precancerous bronchial lesions in high-risk patients: long-term results of the SELEPREBB randomised multicentre trial.
    Eur Respir J. 2022;60.
    PubMed     Abstract available


    August 2022
  5. STANOJEVIC S, Kaminsky DA, Miller M, Thompson B, et al
    Reply: The new ERS/ATS standards on lung function test interpretation: some extant limitations.
    Eur Respir J. 2022;60.
    PubMed    


  6. NEDER JA
    The new ERS/ATS standards on lung function test interpretation: some extant limitations.
    Eur Respir J. 2022;60.
    PubMed    


    July 2022
  7. TISI S, Dickson JL, Horst C, Quaife SL, et al
    Detection of COPD in the SUMMIT Study Lung Cancer Screening Cohort using Symptoms and Spirometry.
    Eur Respir J. 2022 Jul 26. pii: 13993003.00795-2022.
    PubMed     Abstract available


  8. CROSBIE PAJ, Gabe R, Simmonds I, Hancock N, et al
    Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00483-2022.
    PubMed     Abstract available


  9. KALINKE L, Janes SM
    Two phenotypes that predict prognosis in lung adenocarcinoma.
    Eur Respir J. 2022;60.
    PubMed    


  10. LAMORT AS, Kaiser JC, Pepe MAA, Lilis I, et al
    Prognostic phenotypes of early-stage lung adenocarcinoma.
    Eur Respir J. 2022;60.
    PubMed     Abstract available


  11. LOPEZ-ALONSO I, Lopez-Martinez C, Martin-Vicente P, Amado-Rodriguez L, et al
    Mechanical ventilation promotes lung tumour spread by modulation of cholesterol cell content.
    Eur Respir J. 2022;60.
    PubMed     Abstract available


    June 2022
  12. LIU X, Qin H, Li Z, Lv Y, et al
    Inspiratory hyperoxia suppresses lung cancer metastasis through a MYC/SLC1A5-dependent metabolic pathway.
    Eur Respir J. 2022 Jun 9. pii: 13993003.00062-2022.
    PubMed     Abstract available


    May 2022
  13. OKI M, Saka H, Imabayashi T, Himeji D, et al
    Guide sheath versus non-guide sheath method for endobronchial ultrasound-guided biopsy of peripheral pulmonary lesions: a multicentre randomised trial.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    March 2022
  14. OTSUBO K, Kishimoto J, Ando M, Kenmotsu H, et al
    Nintedanib plus chemotherapy for non-small cell lung cancer with IPF: a randomized phase 3 trial.
    Eur Respir J. 2022 Mar 31. pii: 13993003.00380-2022.
    PubMed     Abstract available


  15. SUCCONY L, Gomez-Lopez S, Pennycuick A, Alhendi ASN, et al
    Lrig1 expression identifies airway basal cells with high proliferative capacity and restricts lung squamous cell carcinoma growth.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    January 2022
  16. SUN TY, Hwang G, Pancirer D, Hornbacker K, et al
    Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour.
    Eur Respir J. 2022;59.
    PubMed    


    December 2021
  17. ZHANG J, Guo JR, Huang ZS, Fu WL, et al
    Transbronchial mediastinal cryobiopsy in the diagnosis of mediastinal lesions: a randomised trial.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    November 2021
  18. SOROLLA A, Parisi E, Sorolla MA, Marques M, et al
    Applications of CRISPR technology to lung cancer research.
    Eur Respir J. 2021 Nov 4. pii: 13993003.02610-2021.
    PubMed    


    October 2021
  19. SCHREUDER A, Jacobs C, Lessmann N, Broeders MJ, et al
    Scan-based competing death risk model for reevaluating lung cancer computed tomography screening eligibility.
    Eur Respir J. 2021 Oct 14. pii: 13993003.01613-2021.
    PubMed     Abstract available


  20. HENDRIKS LEL, van Meerbeeck J, Cadranel J
    Targeted adjuvant therapy in non-small cell lung cancer: trick or treat?
    Eur Respir J. 2021;58.
    PubMed    


  21. ASFAHAN S, Elhence P, Dutt N, Niwas Jalandra R, et al
    Digital-Rapid On-site Examination in Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (DEBUT): a proof of concept study for the application of artificial intelligence in the bronchoscopy suite.
    Eur Respir J. 2021;58.
    PubMed    


    September 2021
  22. HENROT P, Beaufils F, Thumerel M, Eyraud E, et al
    Circulating fibrocytes as a new tool to predict lung cancer progression after surgery?
    Eur Respir J. 2021 Sep 24. pii: 13993003.01221-2021.
    PubMed    


    July 2021
  23. LI G, Zhang X, Liu Y, Zhang J, et al
    Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study.
    Eur Respir J. 2021 Jul 29. pii: 13993003.01399-2021.
    PubMed     Abstract available


    June 2021
  24. CHERNBUMROONG S, Johnson J, Gupta N, Miller S, et al
    Machine learning can predict disease manifestations and outcomes in lymphangioleiomyomatosis.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    April 2021
  25. MALDONADO F, Varghese C, Rajagopalan S, Duan F, et al
    Validation of the BRODERS classifier (Benign versus aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    March 2021
  26. HASANI AM, Matthew B, Goljamali M, Chen YC, et al
    Effect of non-uniform cyst distribution in lymphangioleiomyomatosis on pulmonary function: a cross-sectional study.
    Eur Respir J. 2021;57.
    PubMed    


  27. FERNANDES S, Williams G, Williams E, Ehrlich K, et al
    Solitary pulmonary nodule imaging approaches and the role of optical fibre-based technologies.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: